In Utero Metabolic Disruption—A Preventable Antecedent of Adult Disease?
Vicente Mustieles,Mariana F. Fernández,Carmen Messerlian
DOI: https://doi.org/10.1001/jamanetworkopen.2024.12022
2024-05-24
JAMA Network Open
Abstract:The early manifestation of metabolic syndrome (MetS) in children, characterized by the premature onset of visceral obesity, elevated blood pressure, and the progression to dyslipidemia and type 2 diabetes, is associated with adult cardiovascular disease. Tackling the rising epidemic of obesity and MetS demands an exploration of their developmental origins, beginning with the identification of exposures in preconception, prenatal, and early life environments that manifest as modifiable factors for adult diseases. Güilt-Oumrait et al 1 leveraged data from the Human Early Life Exposome project, one of the most extensive population-based, early-life exposome cohorts available. The authors found that elevated maternal prenatal exposure to 4 families of persistent environmental chemicals—metals, organochlorine compounds, polybrominated diphenyl ethers, and perfluoroalkyl substances (PFAS) —was associated with a significant increased risk of MetS in children aged 6 to 11 years. 1 Drawing from preharmonized data amalgamated across 6 European mother-child cohorts, the study also integrated a panel of metabolic markers measured in children's serum and urine. Results from the biomarker analysis added further support to the biological plausibility of the primary associations. This research 1 stands out as one of the most comprehensive endeavors delving into early-life environmental origins of metabolic risk, further bolstering prior toxicological and epidemiological evidence in this area. Endocrine disrupting chemicals (EDCs) are exogenous substances with the ability to alter multiple aspects of hormone action. More recently, some EDCs have been subclassified as obesogens and/or metabolic disruptors based on their ability to promote fat accumulation and hack metabolic signals, especially during critical windows such as fetal and child development. 2 Virtually all of the population is ubiquitously exposed to low doses of numerous EDCs, including the bad actors identified in the present study 1 (mercury, hexachlorobenzene, polybrominated diphenyl ethers 47 and 153, and perfluoro-nonanoic acid), meaning that in utero exposure to these EDCs could predispose or even trigger numerous cases of children's MetS worldwide. Indeed, the health-related costs of population exposure to EDCs have been estimated in hundreds of billions of dollars annually in both the US and the EU. 3 While diagnosing MetS in children poses challenges, its global prevalence is estimated at 3% in childhood, rising to 5% in adolescence. 4 The study's 1 focus on children's MetS as a composite risk score is commendable for several reasons. First, toxicological evidence supports that different families of environmental chemicals can induce convergent multisystemic adverse metabolic effects through both similar and dissimilar modes of action. 2 For instance, long-chain PFAS predominantly accumulate in the liver, contributing to fatty liver disease and dyslipidemia, while other families like organochlorine compounds accumulate in adipose tissue and are associated with obesogenic and diabetogenic effects. Thus, the implemented MetS risk score serves as an optimal and sensitive approach to comprehensively detect EDC-associated metabolic effects. Second, the risk score facilitates the timely identification of environmental, genetic, sociodemographic, and lifestyle risk factors prior to the onset of clinical MetS in children. This expedites primary prevention opportunities and chemical regulatory actions. Third, the MetS score enables the identification of children at high cardiovascular risk, supporting secondary prevention measures that, among others, could involve strategies to reduce the body burden of environmental chemicals. Human exposure to dozens, if not hundreds, of both known and unknown environmental chemicals, exhibiting potential additive effects, is a complex reality. The categorization and regulation of chemicals by families can streamline evaluation and policy measures, aligning with a contemporary regulatory paradigm 5 —a strength echoed by the authors' comprehensive mixture approach. 1 The study's merits extend to its robust sample size compared with previous research, meticulous control for relevant confounders (sociodemographic, anthropometric, and dietary variables), and thoughtful consideration of gestational weight gain. 1 The latter is crucial, given its influence on the kinetics of maternal adipose tissue, impacting systemic levels of lipophilic chemicals stored in fat. Pooling data from various European cohorts with differing confounding structures enhances the study's generalizability and mitigates residual confounding bias. While persistent chemicals exhibit prolonged biological half-lives, allowing for a reliable exposure assessment through a single blood sample, nonpe -Abstract Truncated-
medicine, general & internal